Monthwise SARS CoV-2 mutation statistics
Position | Mutation | Clade |
---|---|---|
30 | nsp8:D30A; | CL-3b; |
50 | nsp8:D50-; | CL-3b; |
50 | nsp8:D50N; | CL-3f; |
52 | nsp8:D52N; | CL-3e;CL-3f; |
64 | nsp8:D64-; | CL-3d; |
99 | nsp8:D99-; | CL-3f; |
99 | nsp8:D99G; | CL-3d; |
155 | nsp8:E155A; | CL-1a; |
155 | nsp8:E155D; | CL-3d; |
155 | nsp8:E155K; | CL-3b; |
171 | nsp8:E171-; | CL-4; |
171 | nsp8:E171D; | CL-3e; |
23 | nsp8:E23D; | CL-1a_3b; |
23 | nsp8:E23G; | CL-3f; |
48 | nsp8:E48D; | CL-1a; |
60 | nsp8:E60D; | CL-3d; |
77 | nsp8:E77A; | CL-3e; |
77 | nsp8:E77D; | CL-3d;CL-3e;CL-3f; |
147 | nsp8:F147L; | CL-2;CL-3e; |
15 | nsp8:F15-; | CL-1a_3e;CL-3e; |
49 | nsp8:F49-; | CL-3e; |
6 | nsp8:F6Y; | CL-3f; |
113 | nsp8:G113-; | CL-3e; |
144 | nsp8:G144D; | CL-2; |
144 | nsp8:G144S; | CL-3d;CL-3e; |
29 | nsp8:G29-; | CL-3e; |
29 | nsp8:G29S; | CL-3b;CL-3c;CL-3e; |
106 | nsp8:I106-; | CL-2;CL-3b; |
119 | nsp8:I119V; | CL-3c;CL-3d; |
132 | nsp8:I132T; | CL-3f; |
132 | nsp8:I132V; | CL-3e; |
156 | nsp8:I156L; | CL-3d; |
156 | nsp8:I156V; | CL-1a;CL-3e;CL-3f;CL-5; |
2 | nsp8:I2M; | CL-1a_3e;CL-3e; |
2 | nsp8:I2T; | CL-3c; |
2 | nsp8:I2V; | CL-3b;CL-3d;CL-3e; |
127 | nsp8:K127R; | CL-3e; |
139 | nsp8:K139-; | CL-1b;CL-2;CL-3b;CL-3c;CL-3e; |
139 | nsp8:K139R; | CL-3b;CL-3c; |
36 | nsp8:K36-; | CL-3b; |
36 | nsp8:K36Q; | CL-3d; |
39 | nsp8:K39R; | CL-1b; |
40 | nsp8:K40N; | CL-3b;CL-3e;CL-3f; |
58 | nsp8:K58-; | CL-3b; |
61 | nsp8:K61-; | CL-3b;CL-3d;CL-3f; |
61 | nsp8:K61N; | CL-3d;CL-3e; |
61 | nsp8:K61R; | CL-2_3a; |
72 | nsp8:K72R; | CL-3d;CL-3e; |
79 | nsp8:K79N; | CL-2; |
79 | nsp8:K79R; | CL-3e; |
Page 339 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com